ArticleKidney international reports2026
Validation of Combining Total Kidney Volume and Kidney Failure Risk Equation in Autosomal Dominant Polycystic Kidney Disease.
Article in Kidney international reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Improving Risk Prediction in ADPKD.Kidney international reports · 2026Article
Corrections and comments
- Commented on by
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Total kidney volume (TKV) interpreted via the Mayo Imaging Classification (MIC) is the recommended prognostication tool in autosomal dominant polycystic kidney disease (ADPKD), but further risk stratification is often needed. The kidney failure risk equation (KFRE) is validated in chronic kidney disease (CKD) of diverse etiologies, but its use in patients with ADPKD already assessed via the MIC is unclear. This study evaluated the impact of adding KFRE to MIC. Methods: Adults with ADPKD with ≥1 computed tomography (CT) or magnetic resonance imaging (MRI) derived TKV available between January 2015 and January 2023 were included in this retrospective observational study. The predictive performance of models including the MIC value, baseline estimated glomerular filtration rate (eGFR), and 5-year KFRE score, and fully adjusted models were examined using the composite outcome of kidney replacement therapy initiation or eGFR decline 40%. The primary analysis was in patients with eGFR < 60 ml/min per 1.73 m Results: In the eGFR < 60 ml/min per 1.73 m Conclusion: In the cohort with a baseline eGFR < 60 ml/min per 1.73 m
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.